The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Role and Relevance of Neurocognitive Assessment in Clinical Trials of Patients With CNS Tumors
Abstract
The inclusion of neurocognitive end points in clinical trials of patients with CNS tumors is increasing. Neurocognitive end points are used to understand what cognitive problems exist before treatment to establish a baseline by which the effect of treatment is judged, and to determine whether different treatment regimens improve neurocognitive function due to better tumor control, slow expected neurocognitive deterioration due to the tumor, or have more or less short- and long-term neurotoxicity. However, the use of neurocognitive end points in clinical trials for patients with CNS tumors is in its infancy, so that long-term outcomes are difficult to predict and the ability to determine the effects of different agents and treatment approaches is scant. Including this aspect of patient evaluation in addition to survival and time to tumor progression will yield better risk-versus-benefit assessments as well as provide a basis for improving interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998) · The Clinical Neuropsychologist · doi:10.1076/clin.12.1.43.1726 · Cited by 1,597
Assessing symptom distress in cancer patients: The M. D. Anderson Symptom Inventory
Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., & Engstrom, M. C. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v · Cited by 1,360
Irradiation induces neural precursor-cell dysfunction
Monje, M. L., Mizumatsu, S., Fike, J. R., & Palmer, T. D. (2002) · Nature Medicine · doi:10.1038/nm749 · Cited by 1,271
Measurement in Neurological Rehabilitation
Cole, M. (1993) · Neurology · doi:10.1212/wnl.43.2.459-b · Cited by 1,011
Roa, W., Brasher, P. M. A., Bauman, G., Anthes, M., Bruera, E., Chan, A., Fisher, B., Fulton, D., Gulavita, S., Hao, C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.082 · Cited by 904
Cognitive deficits in adult patients with brain tumours
Taphoorn, M. J., & Klein, M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00680-5 · Cited by 756
Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone
Rutkowski, S., Bode, U., Deinlein, F., Ottensmeier, H., Warmuth-Metz, M., Soerensen, N., Graf, N., Emser, A., Pietsch, T., Wolff, J. E. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042176 · Cited by 751
Meyers, C. A., Smith, J. A., Bezjak, A., Mehta, M. P., Liebmann, J., Illidge, T., Kunkler, I., Caudrelier, J.-M., Eisenberg, P. D., Meerwaldt, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.128 · Cited by 585
Self-citationMethylphenidate therapy improves cognition, mood, and function of brain tumor patients.
Meyers, C. A., Weitzner, M. A., Valentine, A. D., & Levin, V. A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2522 · Cited by 377
Self-citation
Cited by
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas
Smith, J. S., Chang, E. F., Lamborn, K. R., Chang, S. M., Prados, M. D., Cha, S., Tihan, T., VandenBerg, S., McDermott, M. W., & Berger, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9337 · Cited by 1,283
Brown, P. D., Pugh, S., Laack, N. N., Wefel, J. S., Khuntia, D., Meyers, C., Choucair, A., Fox, S., Suh, J. H., Roberge, D., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not114 · Cited by 958
Self-citationBrown, P. D., Gondi, V., Pugh, S., Tome, W. A., Wefel, J. S., Armstrong, T. S., Bovi, J. A., Robinson, C., Konski, A., Khuntia, D., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02767 · Cited by 846
Self-citationWhy avoid the hippocampus? A comprehensive review
Gondi, V., Tomé, W. A., & Mehta, M. P. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.09.013 · Cited by 398
Li, J., Bentzen, S. M., Renschler, M., & Mehta, M. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2536 · Cited by 337
Metadata
- Authors
- Meyers, C. A., & Brown, P. D.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-03-10
- Volume
- 24
- Issue
- 8
- Pages
- 1305-1309
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2108956608
- Cited by
- 349
- References
- 21
- FWCI
- 12.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role and Relevance of Neurocognitive Assessment in Clinical Trials of Patients With CNS Tumors. https://app.cochat.ai/papers/10.1200/jco.2005.04.6086
- The paper
- Meyers, C. A., & Brown, P. D. (2006). Role and Relevance of Neurocognitive Assessment in Clinical Trials of Patients With CNS Tumors. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2005.04.6086
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
